Statins and highly sensitive cardiac troponins: cardiotoxicity or cross-reactivity?
To date, hypolipidemic drugs of the statin group are among the most popular therapeutic agents used for the prevention and treatment of the most common worldwide atherosclerotic cardiovascular diseases (CVD). Therefore, considerable attention of researchers is focused on statins to study the additio...
Saved in:
Main Authors: | A. M. Chaulin (Author), D. V. Duplyakov (Author) |
---|---|
Format: | Book |
Published: |
Столичная издательская компания,
2023-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cardioprotective Strategies for Doxorubicin-induced Cardiotoxicity: Present and Future
by: A. M. Chaulin, et al.
Published: (2022) -
High Sensitivity Troponin T as Complementary Modality for Determining Doxorubicin Regimen Cardiotoxicity in Non-Hodgkin Lymphoma Patients
by: Ami Ashariati Prayogo, et al.
Published: (2022) -
Ventricular function and high-sensitivity cardiac troponin T in preterm infants with neonatal sepsis
by: Nusarintowati Ramadhina, et al.
Published: (2015) -
Sex-Specific Cut-Offs for High-Sensitivity Cardiac Troponin: Is Less More?
by: Giulio Francesco Romiti, et al.
Published: (2019) -
Prognostic implications of high-sensitivity cardiac troponin in patients with suspected myocardial infarction with or without psoriasis
by: Sanaz A. Guldmann, MD, DPhil, et al.
Published: (2023)